Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Find Exemplary Scents: An Extensive Aide - 2Doctor's orders: Eat ice cream, and other tips for a long and healthy life
- 3Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- 47 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times
- 5New York to require social media platforms to display mental health warnings
- MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
- Interstellar comet 3I/ATLAS reveals weird wobbling jets in rare sun-facing tail
- Astronaut on ISS captures spectacular orbital video of zodiacal light, auroras and the Pleiades
- Qatar LNG Ships U-Turn After Attempt to Pass Through Hormuz
- Viable Monetary Tips to Advance Your Monetary Circumstance
- Astronauts on the ISS watched NASA's historic Artemis 2 launch from space
- NASA probe captures stunning photos of Earth and moon on the way to infamous asteroid Apophis
- Volkswagen in talks with defence firms on use of Germany plant: CEO
- Telecommute Arrangement: What's Pivotal for Your Efficiency?
